The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of adding ovarian function suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or resume menstruation after chemotherapy: The ASTRRA study.
 
Woo Chul Noh
No Relationships to Disclose
 
jong Won Lee
No Relationships to Disclose
 
Seok Jin Nam
No Relationships to Disclose
 
Seho Park
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - AstraZeneca; Hanmi; Novartis; Pfizer; Roche
Research Funding - AstraZeneca
 
Eun Sook Lee
No Relationships to Disclose
 
Yongsik Jung
No Relationships to Disclose
 
Jung Han Yoon
No Relationships to Disclose
 
Sung Soo Kang
No Relationships to Disclose
 
Soo-Jung Lee
No Relationships to Disclose
 
Kyong Hwa Park
Consulting or Advisory Role - Pfizer; Roche
 
Joon Jeong
Honoraria - Alvogen; Bayer; Celltrion; Novartis; Pfizer; Roche; Takeda; Teva/Handok
Research Funding - Alvogen; Dong-A Socio; LG Chem
Travel, Accommodations, Expenses - Korea Pharmaceutical and Bio-Pharma Manufacturers Association; Korean Research based Pharma Industry Association
 
Se-heon Cho
No Relationships to Disclose
 
Sung Yong Kim
No Relationships to Disclose
 
hee Jeong Kim
No Relationships to Disclose
 
Chanheun Park
No Relationships to Disclose
 
Se-Hwan Han
No Relationships to Disclose
 
Wonshik Han
No Relationships to Disclose
 
Min Hee Hur
No Relationships to Disclose
 
Hyun-Ah Kim
Stock and Other Ownership Interests - Hanmi; STCube Pharmaceuticals Inc.